The chemical evolution of DNA-DNA interstrand cross-linkers that recognize defined mixed AT and GC sequences

Journal of the American Chemical Society

Volumn 118, Issue 42, 1996, Pages 10041-10051

  Park, Hyun Ju ^a   Kelly, Robert C ^b   Hurley, Laurence H ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIZELESIN; INDOLE DERIVATIVE; PYRROLE DERIVATIVE;

ALKYLATION; ARTICLE; DNA CROSS LINKING; DNA DNA HYBRIDIZATION; IN VITRO STUDY; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; REACTION ANALYSIS;

EID: 0029904935     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja961678a     Document Type: Article

References (80)

1. (a) Dervan, P. B. Science 1986, 232, 464.
2. (b) Advances in DNA Sequence Specific Agents; Hurley, L. H., Ed.; JAI Press Inc.: Greenwich, CT, 1992; Vol. 1.
3. (c) Stubbe, J.; Kozarich, J. W. Chem. Rev. 1987, 87, 1107.
4. (d) Tomasz, M. Chem. Biol. 1995, 2, 575.
5. (e) Hurley, L. H. Trends Pharmacol. Sci. 1988, 9, 402.
6. (f) Hurley, L. H. J. Med. Chem. 1989, 32, 2027.
7. (g) Molecular Basis of Specificity in Nucleic Acids-Drug Interactions; Pullman, B.; Jortner, J., Eds.; Kluwer Academic Publishers, Netherlands, 1990.
8. (h) Hopkins, P. B.; Millard, J. T.; Woo, J.; Werdner, M. F.; Kirchner, J. J.; Sigurdsson, S. T.; Raucher, S. Tetrahedron 1991, 47, 2475.
9. (i) Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S.; Waring, M., Eds.; Macmillan, London, 1994, Vol. 2.
10. (j) Mountzouris, J. A.; Hurley, L. H. In Bioorganic Chemistry: Nucleic Acids; Hecht, S. M., Ed.; Oxford University Press Inc.: New York, 1996; pp 288-323.
11. (a) Wartell, R. M.; Larson, J. E.; Wells, R. E. J. Biol. Chem. 1974, 249, 6719.
12. (b) Van Dyke, M. W.; Hertzberg, R. P.; Dervan, P. B. Proc. Natl. Acad Sci. U.S.A. 1982, 79, 5470.
13. (c) Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 1376.
14. (d) Zimmer, Ch.; Wahnert, V. Prog. Biophys. Mol. Biol. 1986, 47, 31.
15. (e) Kahne, D. Chem. Biol. 1995, 2, 7, and references therein.
16. (a) Lown, J. W.; Krowicki, K.; Bhat, U. G.; Skorobogaty, A.; Ward, B.; Dabrowiak, J. C. Biochemistry 1986, 25, 7408.
17. (b) Lown, J. W. J. Mol. Recog. 1994, 7, 79.
18. (c) Lown, J. W. Drug Dev. Res. 1995, 34, 145.
19. (a) Wade, W. S.; Mrksich, M.; Dervan, P. B. J. Am. Chem. Soc. 1992, 114, 8783.
20. (b) Geierstanger, B. H.; Mrksich, M.; Dervan, P. B.; Wemmer, D. E. Science 1994, 266, 646.
21. (c) Geierstanger, B. H.; Mrksich, M.; Dervan, P. B.; Wemmer, D. E. Nature Struct. Biol. 1996, 3, 321, and references therein.
22. (a) Hurley, L. H.; Reynolds, V. L.; Swenson, D. H.; Petzold, G. L; Scahill, T. A. Science 1984, 226, 843.
23. (b) Warpehoski, M. A.; Hurley, L. H. Chem. Res. Toxicol. 1988, 1, 315.
24. (c) Hurley, L. H.; Lee, C.-S.; McGovren, J. P.; Warpehoski, M. A.; Mitchell, M. A.; Kelly, R. C.; Aristoff, P. A. Biochemistry 1988, 27, 3886.
25. (d) Hurley, L. H.; Warpehoski, M. A.; Lee, C.-S.; McGovren, J. P.; Scahill, T. A.; Kelly, R. C.; Mitchell, M. A.; Wicnienski, N. A.; Gebhard, I.; Johnson, P. D.; Bradford, V. S. J. Am. Chem. Soc. 1990, 112, 4633.
26. (e) Warpehoski, M. In Advances in DNA Sequence Specific Agents; Hurley, L. H., Ed.; JAI Press Inc.: Greenwich, CT, 1992; Vol. 1, pp 217-245.
27. (f) Hurley, L. H.; Draves, P. H. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M. J., Eds.; Macmillan, London, 1993; Vol. 2; pp 89-133.
28. (g) Boger, D. L; Ishizaki, T.; Zarrinmayeh, H.; Munk, S. A.; Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961.
29. (h) Boger, D. L.; Munk, S. A.; Zarrinmayeh, H.; Ishizaki, T.; Haught, J.; Bina, M. Tetrahedron 1991, 47, 2661.
30. (I) Boger, D. L.; Johnson, D. S.; Palanki, M. S. S.; Kitos, P. A.; Chang, J.; Dowell, P. Bioorg. Med. Chem. 1993, 1, 27.
31. (j) Boger, D. L.; Johnson, D. S.; Yun, W.; Tarby, C. M. Bioorg. Med. Chem. 1994, 2, 115.
32. (k) Boger, D. L.; Johnson, D. S.; Yun, W. J. Am. Chem. Soc. 1994, 116, 1635.
33. (l) Boger, D. L.; Johnson, D. S. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3642.
34. (m) Boger, D. L.; Mésini, P. J. Am. Chem. Soc. 1995, 117, 11647.
35. (a) Hertzberg, R. P.; Hecht, S. M.; Reynolds, V. L.; Molineux, I. J.; Hurley, L. H. Biochemistry 1986, 25, 1249.
36. (b) Tang, M. S.; Nazimiec, M. E.; Doisy, R. P.; Pierce, J. R.; Hurley, L. H.; Alderete, B. E. J. Mol. Biol. 1991, 220, 855.
37. (c) Mountzouris, J. A.; Hurley, L. H. In Advances in DNA Sequence Specific Agents; Hurley, L. H., Ed.; JAI Press Inc.: Greenwich, CT, 1992; Vol. 1, pp 263-292.
38. (d) Kizu, R.; Draves, P. H.; Hurley, L. H. Biochemistry 1993, 32, 8712.
39. (a) Borowy-Borowski, H.; Lipman, R.; Tomasz, M. Biochemistry 1990, 29, 2999.
40. (b) Kumar, S.; Lipman, R.; Tomasz, M. Biochemistry 1992, 31, 1399.
41. (c) Kohn, H.; Li, V.-S.; Tang, M.-s. J. Am. Chem. Soc. 1992, 114, 5501.
42. (d) Kohn, H.; Li, V.-S.; Schiltz, P.; Tang, M.-s. J. Am. Chem. Soc. 1992, 114, 9218.
43. (e) Li, V.-S.; Choi, D.; Tang, M.-s.; Kohn, H. Biochemistry 1995, 34, 7120.
44. (f) Johnson, W. S.; He, Q. Y.; Tomasz, M. Bioorg. Med. Chem. 1995, 3, 851.
45. (g) Li, V.-S.; Choi, D.; Tang, M.-s.; Kohn, H. J. Am. Chem. Soc. 1996, 118, 3765.
46. (a) Hansen, M.; Hurley, L. H. J. Am. Chem. Soc. 1995, 117, 2421.
47. (b) Sun, D.; Hansen, M.; Hurley, L. H. J. Am. Chem. Soc. 1995, 117, 2431.
48. (c) Hansen, M.; Hurley, L. H. Acc. Chem. Res. 1996, 29, 249.
49. (d) Prakash, A. S.; Moore, A. G.; Murray, V.; Matias, C.; McFayden, W. D.; Wickham, G. Chem.-Biol. Interact. 1995, 95, 17-28.
50. (a) Jenkins, T. C.; Hurley, L. H.; Neidle, S.; Thurston, D. E. J. Med. Chem. 1994, 37, 4529.
51. (b) Mountzouris, J. A.; Wang, J.-J.; Thurston, D.; Hurley, L. H. J. Med. Chem. 1994, 37, 3132.
52. (a) Sun, D.; Hurley, L. H. J. Am. Chem. Soc. 1993, 115, 5925.
53. (b) Lee, C.-S.; Pfeifer, G. P.; Gibson, N. W. Biochemistry 1994, 33, 6024.
54. (a) Seaman, F. C.; Hurley, L. H. Biochemistry 1993, 32, 12577.
55. (b) Seaman, F. C.; Hurley, L. H. J. Am. Chem. Soc. 1996, 118, 10052-10064.
56. Mitchell, M. A.; Kelly, R. C.; Wicnienski, N. A.; Hatzenbuhler, N. T.; Williams, M. G.; Petzold, G. C.; Slighton, J. L.; Siemieniak, P. R. J. Am. Chem. Soc. 1991, 113, 8994.
57. (a) Li, L. H.; Kelly, R. C.; Warpehoski, M. A.; McGovren, J. P.; Gebhard, I.; DeKoning, T. F. Invest. New Drugs 1991, 9, 137.
58. (b) Bhuyan, B. K.; Smith, K. S.; Adams, E. G.; Petzold, G. L.; McGovren, J. P. Cancer Res. 1992, 52, 5687.
59. (c) Li, L. H.; DeKoning, T. F.; Kelly, R. C.; Krueger, W. C.; McGovren, J. P.; Padbury, G. E.; Petzold, G. L.; Wallace, T. L.; Ouding, R. J.; Prairie, M. D.; Gebhard, I. Cancer Res. 1992, 52, 4904.
60. For example, versus i.p. implanted murine L1210 leukemia, a single i.v. injection of Bizelesin at 10μg/kg cured (30-day survivors) 50% of the mice. For comparison, Adozelesin increased the life span of such mice by 94% at an optimum dose of 100μg/kg but with no cures.
61. Kelly, R. C., et al., in preparation
62. (a) Thompson, A. S.; Hurley, L. H. J. Am. Chem. Soc. 1995, 117, 2371.
63. (b) Thompson, A. S.; Hurley, L. H. J. Mol. Biol. 1995, 252, 86.
64. Thompson, A. S.; Fan, J.-Y.; Sun, D.; Hansen, M.; Hurley, L. H. Biochemistry 1995, 34, 11005.
65. Reynolds, V. L.; Molineux, I. J.; Kaplan, D. J.; Swenson, D. H.; Hurley, L. H. Biochemistry 1985, 24, 6228.
66. Koo, H.-S.; Wu, H.-M.; Crothers, D. M. Nature 1986, 320, 501.
67. This point has been disputed in the past (ref 5, g-m), but the results and interpretation of this simple experiment are difficult to dismiss, despite complex and confusing arguments to the contrary.
68. Hurley, L. H.; Needham-VanDevanter, D. R.; Lee, C.-S. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 6412.
69. (a) Lin, C. H.; Sun, D.; Hurley, L. H. Chem. Res. Toxicol. 1991, 4, 21.
70. (b) Lin, C. H.; Hill, G. C.; Hurley, L. H. Chem. Res. Toxicol. 1992, 5, 167.
71. (c) Sun, D.; Lin, C. H.; Hurley, L. H. Biochemistry 1993, 30, 4487.
72. (d) Hurley, L. H.; Sun, D. J. Mol. Recog. 1994, 7, 123.
73. Lin, C. H.; Beale, J. M.; Hurley, L. H. Biochemistry 1991, 30, 3597.
74. Warpehoski, M. A.; Harper, D. E. J. Am. Chem. Soc. 1994, 116, 7573.
75. (a) Boyd, F. L.; Cheatham, S. F.; Remers, W.; Barkley, M. D.; Hurley, L. H. Biochemistry 1990, 29, 2387.
76. (b) Wang, J.-J.; Hill, G. C.; Hurley, L. H. J. Med. Chem. 1992, 35, 2995.
77. (c) Bose, D. S.; Thompson, A. S.; Ching, J.; Hartley, J. A.; Berardini, M. D.; Jenkins, T. C. J. Am. Chem. Soc. 1992, 114, 4939.
78. (d) Bose, D. S.; Thompson, A. S.; Smellie, M.; Berardini, M. D.; Hartley, J. A.; Jenkins, T. C.; Neidle, S.; Thurston, D. E. J. Chem. Soc., Chem. Commun. 1992, 20, 1518.
79. Seaman, F. C.; Chu, J.; Hurley, L. H. J. Am. Chem. Soc. 1996, 118, 5383.
80. Lee, C.-S.; Sun, D.; Kizu, R.; Hurley, L. H. Chem. Res. Toxicol. 1991, 4, 203.